2021 Annual Meeting | S14 - Behavioral and Cognitive Neurology
Program Materials Program Evaluations
| 02:00 PM - 02:08 PM EDT | Abstract |
001 - Cortical Microstructure in Primary Progressive Aphasia: a multicenter study
Ignacio Illan-Gala, Sr., MD, PhD |
| 02:08 PM - 02:16 PM EDT | Abstract |
002 - Shorter Survival in Right Hemisphere-Predominant Logopenic Progressive Aphasia
Marina Buciuc, MD |
| 02:16 PM - 02:24 PM EDT | Q&A |
Questions and Answers
|
| 02:24 PM - 02:32 PM EDT | Abstract |
003 - A Highly Efficient Method for Single-Cell Electroporation in Mouse Organotypic Hippocampal Slice Culture
Amy Cheung |
| 02:32 PM - 02:40 PM EDT | Abstract |
004 - Lateralization of Motor Damage Influences the Features of Cognitive Impairment in ALS.
Adriano Chio, MD, FAAN |
| 02:40 PM - 02:48 PM EDT | Abstract |
005 - A different cognitive and behavioral profile in ALS patients with or without C9orf72 expansion
Cristina Moglia |
| 02:48 PM - 03:00 PM EDT | Q&A |
Questions and Answers
|
| Alberto Lleo, MD | Dr. Lleo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Lleo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Lleo has received research support from Instituto de Salud Carlos III. The institution of Dr. Lleo has received research support from Generalitat de Calalunya (PERIS). The institution of Dr. Lleo has received research support from BBVA Foundation. The institution of Dr. Lleo has received research support from La Caixa Foundation. Dr. Lleo has received intellectual property interests from a discovery or technology relating to health care. |
| Nha Trang Thu Pham | Nha Trang Thu Pham has received personal compensation for serving as an employee of Mayo Clinic. |
| Juan Fortea, MD, PhD | Dr. Fortea has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Fortea has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AC Inmune. Dr. Fortea has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Fortea has received research support from NIH. Dr. Fortea has received intellectual property interests from a discovery or technology relating to health care. |
| Barbara Iazzolino | No disclosure on file |
| Keith A. Josephs, Jr., MD, FAAN | Dr. Josephs has nothing to disclose. |
| No disclosure on file | |
| Adriano Chio, MD, FAAN | Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. |
| Umberto Manera, MD | Dr. Manera has nothing to disclose. |
| Howard J. Rosen, MD | Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharmaceuticals. Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. The institution of Dr. Rosen has received research support from NIH. The institution of Dr. Rosen has received research support from State of CA. Dr. Rosen has a non-compensated relationship as a Consultant with Alector that is relevant to AAN interests or activities. Dr. Rosen has a non-compensated relationship as a Consultant with Prevail Therapeutics that is relevant to AAN interests or activities. Dr. Rosen has a non-compensated relationship as a consultant with Alchemab that is relevant to AAN interests or activities. |
| Andrea Calvo, MD, PhD, FAAN | Dr. Calvo has nothing to disclose. |
| Jonathan Graff-Radford, MD, FAAN | Dr. Graff-Radford has received personal compensation for serving as an employee of Mayo Clinic. Dr. Graff-Radford has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS/NIH. The institution of Dr. Graff-Radford has received research support from NIH. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Cognition therapeutics. |
| Jennifer Whitwell, PhD | Dr. Whitwell has nothing to disclose. |
| Cristina Moglia | Cristina Moglia has nothing to disclose. |
| Val J. Lowe, MD | Dr. Lowe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AVID Radiopharmaceutical. Dr. Lowe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Inc. The institution of Dr. Lowe has received research support from AVID Radiopharmaceuticals. |
| Antonio Canosa | Antonio Canosa has nothing to disclose. |
| Dennis W. Dickson, MD | Dr. Dickson has nothing to disclose. |
| Francesca Palumbo | No disclosure on file |
| Rosario Vasta, MD | Dr. Vasta has nothing to disclose. |
| Maura Brunetti | No disclosure on file |
| Clifford R. Jack, Jr., MD | The institution of Dr. Jack has received research support from NIH. The institution of Dr. Jack has received research support from Alexander Family Alzheimer's Disease Research Professorship of the Mayo Clinic. |
| Bruce L. Miller, MD, FAAN | Dr. Miller has nothing to disclose. |
| Ignacio Illan-Gala, Sr., MD, PhD | Dr. Illan-Gala has nothing to disclose. |
| Neus Falgàs Martínez | Neus Falgàs Martínez has nothing to disclose. |
| Maria Luisa Gorno Tempini, MD, PhD | The institution of Dr. Gorno Tempini has received research support from NIH. |
| Joseph Duffy | No disclosure on file |
| Marina Buciuc, MD | Dr. Buciuc has nothing to disclose. |
| Matthew Senjem | Matthew Senjem has received stock or an ownership interest from Align Technology, Inc.. Matthew Senjem has received stock or an ownership interest from Inovio Biomedical Corp.. Matthew Senjem has received stock or an ownership interest from Johnson & Johnson. Matthew Senjem has received stock or an ownership interest from Mesa Laboratories, Inc.. Matthew Senjem has received stock or an ownership interest from Nvidia Inc.. Matthew Senjem has received stock or an ownership interest from LHC Group, Inc.. Matthew Senjem has received stock or an ownership interest from Natus Medical Incorporated. Matthew Senjem has received stock or an ownership interest from Varex Imaging Corporation. Matthew Senjem has received personal compensation in the range of $100,000-$499,999 for serving as a IT Technical Specialist II with Mayo Clinic. |
| Rafael G. Blesa, MD | Dr. Blesa has nothing to disclose. |
| Amy Cheung | Ms. Cheung has nothing to disclose. |
| Mary M. Machulda, PhD | The institution of Dr. Machulda has received research support from NIH. |
| Daniel Alcolea Rodriguez | Daniel Alcolea Rodriguez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Diagnostics. Daniel Alcolea Rodriguez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fujirebio Europe. Daniel Alcolea Rodriguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Fujirebio Europe. Daniel Alcolea Rodriguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Diagnostics. Daniel Alcolea Rodriguez has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Nutricia. The institution of Daniel Alcolea Rodriguez has received research support from Fujirebio - Europe. Daniel Alcolea Rodriguez has received intellectual property interests from a discovery or technology relating to health care. |
| Victor Montal | No disclosure on file |
| Kimiko Domoto-Reilly, MD | Dr. Domoto-Reilly has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MedBridge. The institution of Dr. Domoto-Reilly has received research support from Lawson Health Research Institute. The institution of Dr. Domoto-Reilly has received research support from NIH. The institution of Dr. Domoto-Reilly has received research support from Biogen. The institution of Dr. Domoto-Reilly has received research support from Lewy Body Dementia Association. The institution of Dr. Domoto-Reilly has received research support from Garvey Institute for Brain Health Solutions. The institution of Dr. Domoto-Reilly has received research support from Cognition Therapeutics. The institution of Dr. Domoto-Reilly has received research support from Takayama Family. |
| Victor W. Henderson, MD, FAAN | Dr. Henderson has stock in Abbott, Amgen, Roche. The institution of Dr. Henderson has received research support from NIH. The institution of Dr. Henderson has received research support from Health IQ. Dr. Henderson has received personal compensation in the range of $500-$4,999 for serving as a External advisory committee member, Alzheimer's Disease Center with University of Kansas. Dr. Henderson has a non-compensated relationship as a adjunct (honorary) professor with Aarhus University that is relevant to AAN interests or activities. |